Literature DB >> 25986697

The histamine H4-receptor and the central and peripheral nervous system: A critical analysis of the literature.

Erich H Schneider1, Roland Seifert2.   

Abstract

Expression and function of histamine H4R in central and peripheral nervous system have been a matter of controversy for more than a decade. The scientific discussion is often limited to a few publications postulating the presence of functional H4R on neurons of the central and peripheral nervous system, but the even larger number of reports showing negative data is often neglected. In this article, we critically review the existing literature on H4R in central and peripheral nervous system and discuss the weak points often overlooked by the community. We identified as most important problems (i) insufficient validation or quality of antibodies, (ii) missing knockout controls, (iii) uncritical interpretation of RT-PCR results instead of qPCR experiments, (iv) insufficient controls to confirm specificity of pharmacological tools, (v) uncritical reliance on results produced by a single method and (vi) uncritical reliance on results not reproduced by independent research groups. Additionally, there may be a publication as well as a citation bias favoring the awareness of positive results, but neglecting negative data. We conclude that H4R expression on neurons of the brain is not convincingly supported by the current literature, at least as long as the positive data are not reproduced by independent research groups. Expression and function of H4R on peripheral neurons or non-neuronal cells of the nervous system, specifically on microglia is an interesting alternative hypothesis that, however, requires further verification. This article is part of a Special Issue entitled 'Histamine Receptors'.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody specificity; Histamine H(4) receptor; Microglia; Nervous system; Neuron; Publication bias

Mesh:

Substances:

Year:  2015        PMID: 25986697     DOI: 10.1016/j.neuropharm.2015.05.004

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  25 in total

1.  Heterologous, PKC-Mediated Desensitization of Human Histamine H3 Receptors Expressed in CHO-K1 Cells.

Authors:  Wilber Montejo-López; Nayeli Rivera-Ramírez; Juan Escamilla-Sánchez; Ubaldo García-Hernández; José-Antonio Arias-Montaño
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

Review 2.  Brain histamine modulates recognition memory: possible implications in major cognitive disorders.

Authors:  Gustavo Provensi; Alessia Costa; Ivan Izquierdo; Patrizio Blandina; Maria Beatrice Passani
Journal:  Br J Pharmacol       Date:  2018-09-22       Impact factor: 8.739

3.  Histaminergic Control of Corticostriatal Synaptic Plasticity during Early Postnatal Development.

Authors:  Sungwon Han; Ricardo Márquez-Gómez; Myles Woodman; Tommas Ellender
Journal:  J Neurosci       Date:  2020-07-24       Impact factor: 6.167

Review 4.  Pruritus in allergy and immunology.

Authors:  Ting-Lin B Yang; Brian S Kim
Journal:  J Allergy Clin Immunol       Date:  2019-08       Impact factor: 10.793

Review 5.  Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutants in the Sf9 Cell Expression System.

Authors:  Erich H Schneider; Roland Seifert
Journal:  Handb Exp Pharmacol       Date:  2017

Review 6.  Histidine Decarboxylase Knockout Mice as a Model of the Pathophysiology of Tourette Syndrome and Related Conditions.

Authors:  Christopher Pittenger
Journal:  Handb Exp Pharmacol       Date:  2017

7.  Histamine H3 Receptor Activation Modulates Glutamate Release in the Corticostriatal Synapse by Acting at CaV2.1 (P/Q-Type) Calcium Channels and GIRK (KIR3) Potassium Channels.

Authors:  Héctor Vázquez-Vázquez; Carolina Gonzalez-Sandoval; Ana V Vega; José-Antonio Arias-Montaño; Jaime Barral
Journal:  Cell Mol Neurobiol       Date:  2020-10-17       Impact factor: 5.046

8.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

9.  Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice.

Authors:  Maristella Adami; Cristina Micheloni; Daniela Grandi; Holger Stark
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-25       Impact factor: 3.000

10.  Developing high-quality mouse monoclonal antibodies for neuroscience research - approaches, perspectives and opportunities.

Authors:  Belvin Gong; Karl D Murray; James S Trimmer
Journal:  N Biotechnol       Date:  2015-11-28       Impact factor: 5.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.